<p>LifeStance Health Group (LFST) 的股价在公司宣布盈利能力改善和全年调整后息税折旧摊销前利润（Adjusted EBITDA）预测超出华尔街预期后上涨。这一消息得到了纽约联邦储备银行行长关于利率的鼓舞人心的评论的进一步支持。</p>
<p>查看我们对 LifeStance Health Group 的最新分析。</p>
<p>LifeStance Health Group 的股价在过去一个月内急剧反弹，涨幅超过 23%，因为对盈利能力和利率的乐观情绪推动了市场动能。尽管股东在过去三年内的总回报接近 36%，但最近一年的总股东回报却为 -15%。这突显出复苏仍在稳步进行中，但显示出对未来增长的 renewed interest。</p>
<p>如果今天医疗股的动能引起了你的注意，这可能是通过我们的免费完整列表发现新竞争者的完美时机。</p>
<p>股价已经反弹；然而，考虑到混合的盈利指引和持续的市场乐观情绪，投资者不禁想知道 LifeStance Health Group 是否真的被低估，或者最新的涨幅是否已经反映了未来的增长潜力。</p>
<h2>最受欢迎的叙述：23.6% 被低估</h2>
<p>LifeStance Health Group 最新的收盘价低于该叙述的公允价值估计，暗示如果增长假设得以实现，未来可能会有上涨空间。该叙述强调了快速扩张的故事，并为未来几年的潜在转型奠定了基础。</p>
<blockquote>
<p>&#34;对人工智能和数字技术平台（如自动化收入周期工具、患者参与系统和增强护理匹配）的投资预计将推动运营杠杆，降低行政成本，提高临床医生的生产力。这些变化可能会在长期内带来更高的净利润率和增加的收益。&#34;</p>
</blockquote>
<p>阅读完整叙述。</p>
<p>想知道是什么推动了这些大规模估值判断吗？发现这一乐观前景背后的关键增长驱动因素、利润预测和一个令人惊讶的财务飞跃。完整的叙述将所有要素连接起来——找出推动这一潜在转机的假设。</p>
<p><strong>结果：公允价值为 $8.43（被低估）</strong></p>
<p>完整阅读叙述，了解预测背后的原因。</p>
<p>然而，竞争加剧和持续的报销压力可能会限制 LifeStance 的增长潜力，如果行业动态在未来几年意外变化。</p>
<p>了解 LifeStance Health Group 叙述的关键风险。</p>
<h2>另一种观点：倍数说了什么？</h2>
<p>超越未来现金流假设，LifeStance Health Group 的市销率为 1.8 倍，明显高于同行和更广泛的医疗行业平均水平 1.3 倍。与公允比率（同样为 1.3 倍）相比，目前的估值似乎偏高，并引发了市场预期变化时的上涨风险问题。投资者是否为预期的增长支付了过高的价格，还是溢价反映了公司的独特前景？</p>
<p>查看数字对这一价格的看法——在我们的估值分析中了解更多。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e421b528-b565-4b30-a932-6e525e138818/chart/ps-multiple-vs-industry?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e421b528-b565-4b30-a932-6e525e138818/chart/ps-multiple-vs-industry"/></p>
<p>纳斯达克：LFST 市销率截至 2025 年 11 月</p>
<h2>自己构建 LifeStance Health Group 的叙述</h2>
<p>如果你想深入挖掘或从不同角度看待问题，你可以在几分钟内塑造自己的 LifeStance Health Group 故事。按照你的方式进行。</p>
<p>一个好的起点是我们的分析，强调投资者对 LifeStance Health Group 的 3 个关键回报的乐观情绪。</p>
<h2>寻找更多投资想法？</h2>
<p>通过精心挑选符合你策略的股票，抓住新兴机会。利用这些强大且易于使用的筛选工具，获得你所需的优势。</p>
<ul>
<li>通过抓住科技领域的动能，解锁快速增长潜力，关注这 26 只人工智能便士股。</li>
<li>通过关注这些 15 只收益率超过 3% 的股息股票，捕捉稳定的收入来源。</li>
<li>通过投资这些 81 只加密安全和区块链股票，站在创新的前沿。</li>
</ul>
<p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也不考虑你的目标或财务状况。我们旨在为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

LFST

<p>LifeStance Health 集团的股票在宣布盈利能力改善和乐观的 EBITDA 预测后上涨。该股票在一个月内反弹了 23%，受益于利率乐观情绪。尽管三年回报率为 36%，但一年回报率为-15%。市场认为该公司被低估了 23.6%，合理价值为 8.43 美元。对人工智能和数字平台的投资预计将提升利润率。然而，竞争和报销压力带来了风险。市销率高于行业平均水平，引发了估值担忧</p>

<p>LifeStance Health Group (LFST) shares climbed after the company announced better profitability and a full-year Adjusted EBITDA forecast above Wall Street expectations. This was further supported by encouraging comments on interest rates from the New York Federal Reserve President.</p>
<div class="lb-trans"><p>LifeStance Health Group (LFST) 的股价在公司宣布盈利能力改善和全年调整后息税折旧摊销前利润（Adjusted EBITDA）预测超出华尔街预期后上涨。这一消息得到了纽约联邦储备银行行长关于利率的鼓舞人心的评论的进一步支持。</p>
</div><p>See our latest analysis for LifeStance Health Group.</p>
<div class="lb-trans"><p>查看我们对 LifeStance Health Group 的最新分析。</p>
</div><p>LifeStance Health Group’s shares have rebounded sharply, jumping over 23% in the past month as optimism about profitability and interest rates fueled momentum. While shareholders have seen a 3-year total return of nearly 36%, the recent 1-year total shareholder return lags at -15%. This highlights a recovery that is still gaining its footing but shows signs of renewed interest around future growth.</p>
<div class="lb-trans"><p>LifeStance Health Group 的股价在过去一个月内急剧反弹，涨幅超过 23%，因为对盈利能力和利率的乐观情绪推动了市场动能。尽管股东在过去三年内的总回报接近 36%，但最近一年的总股东回报却为 -15%。这突显出复苏仍在稳步进行中，但显示出对未来增长的 renewed interest。</p>
</div><p>If today's momentum in healthcare stocks caught your attention, this could be the perfect moment to discover new contenders through our See the full list for free.</p>
<div class="lb-trans"><p>如果今天医疗股的动能引起了你的注意，这可能是通过我们的免费完整列表发现新竞争者的完美时机。</p>
</div><p>The share price has rebounded; however, with mixed earnings guidance and ongoing market optimism, investors are left wondering whether LifeStance Health Group is genuinely undervalued or if the latest gains already reflect future growth potential.</p>
<div class="lb-trans"><p>股价已经反弹；然而，考虑到混合的盈利指引和持续的市场乐观情绪，投资者不禁想知道 LifeStance Health Group 是否真的被低估，或者最新的涨幅是否已经反映了未来的增长潜力。</p>
</div><h2>Most Popular Narrative: 23.6% Undervalued</h2>
<div class="lb-trans"><h2>最受欢迎的叙述：23.6% 被低估</h2>
</div><p>LifeStance Health Group’s latest closing price sits below the narrative’s fair value estimate, signaling possible upside ahead if growth assumptions are realized. The narrative highlights a rapid expansion story and sets the stage for a potentially transformative few years.</p>
<div class="lb-trans"><p>LifeStance Health Group 最新的收盘价低于该叙述的公允价值估计，暗示如果增长假设得以实现，未来可能会有上涨空间。该叙述强调了快速扩张的故事，并为未来几年的潜在转型奠定了基础。</p>
</div><blockquote>
<p>&#34;Investments in AI and digital technology platforms (such as automated revenue cycle tools, patient engagement systems, and enhanced care matching) are expected to drive operating leverage, reduce administrative costs, and improve clinician productivity. These changes may result in higher net margins and increased earnings over the longer term.&#34;</p>
</blockquote>
<div class="lb-trans"><blockquote>
<p>&#34;对人工智能和数字技术平台（如自动化收入周期工具、患者参与系统和增强护理匹配）的投资预计将推动运营杠杆，降低行政成本，提高临床医生的生产力。这些变化可能会在长期内带来更高的净利润率和增加的收益。&#34;</p>
</blockquote>
</div><p>Read the complete narrative.</p>
<div class="lb-trans"><p>阅读完整叙述。</p>
</div><p>Want to know what powers these big valuation calls? Discover the pivotal growth drivers, margin forecasts, and one surprising financial leap behind this bullish outlook. The full narrative connects all the dots—find the assumptions driving this potential turnaround.</p>
<div class="lb-trans"><p>想知道是什么推动了这些大规模估值判断吗？发现这一乐观前景背后的关键增长驱动因素、利润预测和一个令人惊讶的财务飞跃。完整的叙述将所有要素连接起来——找出推动这一潜在转机的假设。</p>
</div><p><strong>Result: Fair Value of $8.43 (UNDERVALUED)</strong></p>
<div class="lb-trans"><p><strong>结果：公允价值为 $8.43（被低估）</strong></p>
</div><p>Have a read of the narrative in full and understand what's behind the forecasts.</p>
<div class="lb-trans"><p>完整阅读叙述，了解预测背后的原因。</p>
</div><p>However, intensifying competition and ongoing reimbursement pressure could limit LifeStance’s growth potential if industry dynamics shift unexpectedly in the coming years.</p>
<div class="lb-trans"><p>然而，竞争加剧和持续的报销压力可能会限制 LifeStance 的增长潜力，如果行业动态在未来几年意外变化。</p>
</div><p>Find out about the key risks to this LifeStance Health Group narrative.</p>
<div class="lb-trans"><p>了解 LifeStance Health Group 叙述的关键风险。</p>
</div><h2>Another View: What Do Multiples Say?</h2>
<div class="lb-trans"><h2>另一种观点：倍数说了什么？</h2>
</div><p>Looking beyond future cash flow assumptions, LifeStance Health Group trades on a Price-to-Sales ratio of 1.8x, noticeably higher than both peers and the broader healthcare industry average of 1.3x. Compared to the fair ratio, also at 1.3x, the current valuation appears rich and raises questions about upside risks if market expectations shift. Are investors paying too much for anticipated growth, or does a premium reflect the company’s unique prospects?</p>
<div class="lb-trans"><p>超越未来现金流假设，LifeStance Health Group 的市销率为 1.8 倍，明显高于同行和更广泛的医疗行业平均水平 1.3 倍。与公允比率（同样为 1.3 倍）相比，目前的估值似乎偏高，并引发了市场预期变化时的上涨风险问题。投资者是否为预期的增长支付了过高的价格，还是溢价反映了公司的独特前景？</p>
</div><p>See what the numbers say about this price — find out in our valuation breakdown.</p>
<div class="lb-trans"><p>查看数字对这一价格的看法——在我们的估值分析中了解更多。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e421b528-b565-4b30-a932-6e525e138818/chart/ps-multiple-vs-industry" alt="" original-src="https://images.simplywall.st/company/e421b528-b565-4b30-a932-6e525e138818/chart/ps-multiple-vs-industry"/></p>
<p>NasdaqGS:LFST PS Ratio as at Nov 2025</p>
<div class="lb-trans"><p>纳斯达克：LFST 市销率截至 2025 年 11 月</p>
</div><h2>Build Your Own LifeStance Health Group Narrative</h2>
<div class="lb-trans"><h2>自己构建 LifeStance Health Group 的叙述</h2>
</div><p>If you want to dig deeper or see things from a different angle, you can shape your own LifeStance Health Group story in just a few minutes. Do it your way</p>
<div class="lb-trans"><p>如果你想深入挖掘或从不同角度看待问题，你可以在几分钟内塑造自己的 LifeStance Health Group 故事。按照你的方式进行。</p>
</div><p>A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding LifeStance Health Group.</p>
<div class="lb-trans"><p>一个好的起点是我们的分析，强调投资者对 LifeStance Health Group 的 3 个关键回报的乐观情绪。</p>
</div><h2>Looking for More Investment Ideas?</h2>
<div class="lb-trans"><h2>寻找更多投资想法？</h2>
</div><p>Capitalize on emerging opportunities by handpicking stocks tailored to your strategy. Gain the edge you need with these powerful, easy-to-use screeners.</p>
<div class="lb-trans"><p>通过精心挑选符合你策略的股票，抓住新兴机会。利用这些强大且易于使用的筛选工具，获得你所需的优势。</p>
</div><ul>
<li>Unlock rapid growth potential by seizing the momentum in tech with these 26 AI penny stocks.</li>
<li>Capture resilient income streams by targeting market leaders that pay attractive yields through these 15 dividend stocks with yields &gt; 3%.</li>
<li>Position yourself at the forefront of innovation by tapping into breakthroughs in cryptographic security with these 81 cryptocurrency and blockchain stocks.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过抓住科技领域的动能，解锁快速增长潜力，关注这 26 只人工智能便士股。</li>
<li>通过关注这些 15 只收益率超过 3% 的股息股票，捕捉稳定的收入来源。</li>
<li>通过投资这些 81 只加密安全和区块链股票，站在创新的前沿。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也不考虑你的目标或财务状况。我们旨在为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

分析 LifeStance Health Group（LFST）在盈利能力改善和指导方针调整后的估值